Skip to content

Simple, Mobile-based Artificial Intelligence AlgoRithms in the Detection of Diabetic ReTinopathy (SMART) Study

Simple, Mobile-based Artificial Intelligence AlgoRithms in the Detection of Diabetic ReTinopathy (SMART) Study

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03572699
Acronym
SMART
Enrollment
900
Registered
2018-06-28
Start date
2018-07-11
Completion date
2018-10-31
Last updated
2018-10-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic Retinopathy

Brief summary

This is an observational cross sectional study aimed to evaluate the performance of the artificial intelligence algorithm in detecting any grade of diabetic retinopathy using retinal images from patients with diabetes.

Interventions

OTHERdiabetic retinopathy

This is an observational study of patients with diabetes. Patients undergoing routine care will undergo retinal imaging using a nonmydriatic fundus camera. The images will be run on an artificial intelligence (AI) algorithm. The diagnosis of the artificial intelligence algorithm will be compared to the image diagnosis given by the ophthalmologists. The ophthalmologists will be blinded to the diagnosis of the AI and vice versa. The data will be analyzed to evaluate the performance of the AI.

Sponsors

Diacon Hospital
CollaboratorOTHER
Medios Technologies Pte. Ltd
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Patients with type 1 or type 2 diabetes mellitus 2. Ages 18 and above 3. Male and female

Exclusion criteria

1. Persistent visual impairment in one or both eyes; 2. Subjects with corneal opacities and advanced cataract. 3. History of retinal vascular (vein or artery) occlusion; 4. Subject is contraindicated for fundus photography (for example, has light sensitivity); 5. Subject is currently enrolled in an interventional study of an investigational device or drug; 6. Subject has a condition or is in a situation which in the opinion of the Investigator, might confound study results, may interfere significantly with the subject's participation in the study, or may result in ungradable clinical reference standard photographs.

Design outcomes

Primary

MeasureTime frame
Sensitivity and specificity of the AI in detecting any grade of diabetic retinopathy3 months

Secondary

MeasureTime frame
Sensitivity and specificity of the AI in detecting referable diabetic retinopathy (referable retinopathy defined as moderate non proliferative retinopathy or greater)3 months
Sensitivity and specificity of the AI in detecting sight threatening diabetic retinopathy (referable retinopathy defined as severe non proliferative retinopathy or greater)3 months

Countries

India

Contacts

Primary ContactSrikanth Y N, MS
srikanthyn@yahoo.com9886450550
Backup ContactBhavana Sosale, MD
bhavanasosale@gmail.com9449478512

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026